Name: The Discovery of Target Antigens for Dysfunctional T Cells in ME/CFS and Long COVID
Start: 2026-04-28T15:00:00-07:00
End: 2026-04-28T16:00:00-07:00

April 2026
GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups

April 16 @ 8:30 am - 9:30 am PDT

Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar in people with Type 2 diabetes and promote substantial weight loss for individuals with a high body mass index (BMI) by slowing digestion, reducing appetite, […]

Free
The Discovery of Target Antigens for Dysfunctional T Cells in ME/CFS and Long COVID

April 28 @ 3:00 pm - 4:00 pm PDT

Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst Award for their study searching for the exact proteins recognized by T-cell receptors from a person with ME/CFS and a person with Long Covid. These disease-associated T cells include “exhausted” CD8+ T cells and “double-positive” CD4+/CD8+ T cells (which are […]

Free

April 2026

GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups

The Discovery of Target Antigens for Dysfunctional T Cells in ME/CFS and Long COVID

Solve ME/CFS Initiative

Explore

Donate

Join our newsletter

Your gift is DOUBLED through April 30!